A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury

Journal of Immunology

Volumn 181, Issue 11, 2009, Pages 8068-8076

  Huang, Yuxiang ^a   Qiao, Fei ^a   Atkinson, Carl ^a   Holers, V Michael ^b   Tomlinson, Stephen ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; RECOMBINANT PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURFACE; COMPLEMENT ALTERNATIVE PATHWAY; CONTROLLED STUDY; IN VITRO STUDY; INTESTINE ISCHEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN TARGETING; REPERFUSION INJURY;

EID: 71849106514     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.11.8068     Document Type: Article

References (30)

1. Rother, K., G. O. Till, and G. M. Haensch, eds. 1998. The Complement System. Springer-Verlag, Berlin.
2. Harboe, M., G. Ulvund, L. Vien, M. Fung, and T. E. Mollnes. 2004. The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin. Exp. Immunol. 138: 439-446. (Pubitemid 39573623)
3. Holers, V. M., and J. M. Thurman. 2004. The alternative pathway of complement in disease: opportunities for therapeutic targeting. Mol. Immunol. 41: 147-152. (Pubitemid 38668624)
4. Thurman, J. M., and V. M. Holers. 2006. The central role of the alternative complement pathway in human disease. J. Immunol. 176: 1305-1310.
5. Ferreira, V. P., A. P. Herbert, H. G. Hocking, P. N. Barlow, and M. K. Pangburn. 2006. Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces. J. Immunol. 177: 6308-6316.
6. Oppermann, M., T. Manuelian, M. Jozsi, E. Brandt, T. S. Jokiranta, S. Heinen, S. Meri, C. Skerka, O. Gotze, and P. F. Zipfel. 2006. The C-terminus of complement regulator factor H mediates target recognition: evidence for a compact conformation of the native protein. Clin. Exp. Immunol. 144: 342-352.
7. Jozsi, M., M. Oppermann, J. D. Lambris, and P. F. Zipfel. 2007. The C-terminus of complement factor H is essential for host cell protection. Mol. Immunol. 44: 2697-2706. (Pubitemid 46240314)
8. Jokiranta, T. S., J. Hellwage, V. Koistinen, P. F. Zipfel, and S. Meri. 2000. Each of the three binding sites on complement factor H interacts with a distinct site on C3b. J. Biol. Chem. 275: 27657-27662.
9. Schmidt, C. Q., A. P. Herbert, H. G. Hocking, D. Uhrin, and P. N. Barlow. 2008. Translational mini-review series on complement factor H: structural and functional correlations for factor H. Clin. Exp. Immunol. 151: 14-24. (Pubitemid 350231000)
10. Alexander, J. J., and R. J. Quigg. 2007. The simple design of complement factor H: looks can be deceiving. Mol. Immunol. 44: 123-132.
11. Atkinson, C., H. Song, B. Lu, F. Qiao, T. A. Burns, V. M. Holers, G. C. Tsokos, and S. Tomlinson. 2005. Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection. J. Clin. Invest. 115: 2444-2453. (Pubitemid 41266206)
12. Hart, M. L., K. A. Ceonzo, L. A. Shaffer, K. Takahashi, R. P. Rother, W. R. Reenstra, J. A. Buras, and G. L. Stahl. 2005. Gastrointestinal ischemiareperfusion injury is lectin complement pathway dependent without involving C1q. J. Immunol. 174: 6373-6380.
13. Stahl, G. L., Y. Xu, L. Hao, M. Miller, J. A. Buras, M. Fung, and H. Zhao. 2003. Role for the alternative complement pathway in ischemia/reperfusion injury. Am. J. Pathol. 162: 449-455. (Pubitemid 36267852)
14. Kinoshita, T., G. Thyphronitis, G. C. Tsokos, F. D. Finkelman, K. Hong, H. Sakai, and K. Inoue. 1990. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor. Int. Immunol. 2: 651-659. (Pubitemid 20232464)
15. Ohta, R., N. Kondor, N. Dohi, S. Tomlinson, M. Imai, V. M. Holers, H. Okada, and N. Okada. 2004. Mouse complement receptor-related gene y/p65-neutralized tumor vaccine induces antitumor activity in vivo. J. Immunol. 173: 205-213. (Pubitemid 38797343)
16. Song, H., C. He, C. Knaak, J. M. Guthridge, V. M. Holers, and S. Tomlinson. 2003. Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation. J. Clin. Invest. 111: 1875-1885. (Pubitemid 38057732)
17. Quigg, R. A., Y. Kozono, D. Berthiaume, A. Lim, J. Salant, A. Weinfeld, P. Griffin, E. Kremmer, and V. M. Holers. 1998. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor. J. Immunol. 160: 4553-4560. (Pubitemid 28217315)
18. Fleming, S. D., M. Monestier, and G. C. Tsokos. 2004. Accelerated ischemia/ reperfusion-induced injury in autoimmunity-prone mice. J. Immunol. 173: 4230-4235. (Pubitemid 39280789)
19. Wada, K., M. C. Montalto, and G. L. Stahl. 2001. Inhibition of complement C5 reduces local and remote organ injury after intestinal ischemia/reperfusion in the rat. Gastroenterology 120: 126-133. (Pubitemid 32061876)
20. Austen, W. G., Jr., L. Kobzik, M. C. Carroll, H. B. Hechtman, and F. D. Moore, Jr. 2003. The role of complement and natural antibody in intestinal ischemia-reperfusion injury. Int. J. Immunopathol. Pharmacol. 16: 1-8.
21. Fleming, S. D., D. Mastellos, G. Karpel-Massler, T. Shea-Donohue, J. D. Lambris, and G. C. Tsokos. 2003. C5a causes limited, polymorphonuclear cell-independent, mesenteric ischemia/reperfusion-induced injury. Clin. Immunol. 108: 263-273.
22. Zhao, H., M. C. Montalto, K. J. Pfeiffer, L. Hao, and G. L. Stahl. 2002. Murine model of gastrointestinal ischemia associated with complement-dependent injury. J. Appl. Physiol. 93: 338-345. (Pubitemid 34686230)
23. Selander, B., U. Martensson, A. Weintraub, E. Holmstrom, M. Matsushita, S. Thiel, J. C. Jensenius, L. Truedsson, and A. G. Sjoholm. 2006. Mannanbinding lectin activates C3 and the alternative complement pathway without involvement of C2. J. Clin. Invest. 116: 1425-1434.
24. Rehrig, S., S. D. Fleming, J. Anderson, J. M. Guthridge, J. Rakstang, C. E. McQueen, V. M. Holers, G. C. Tsokos, and T. Shea-Donohue. 2001. Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice. J. Immunol. 167: 5921-5927. (Pubitemid 33062787)
25. Conner, W. C., C. M. Gallagher, T. J. Miner, H. Tavaf-Motamen, K. M. Wolcott, and T. Shea-Donohue. 1999. Neutrophil priming state predicts capillary leak after gut ischemia in rats. J. Surg. Res. 84: 24-30.
26. Cheng, Z. Z., J. Hellwage, H. Seeberger, P. F. Zipfel, S. Meri, and T. S. Jokiranta. 2006. Comparison of surface recognition and C3b binding properties of mouse and human complement factor H. Mol. Immunol. 43: 972-979.
27. Jokiranta, T. S., Z. Z. Cheng, H. Seeberger, M. Jozsi, S. Heinen, M. Noris, G. Remuzzi, R. Ormsby, D. L. Gordon, S. Meri, et al. 2005. Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site. Am. J. Pathol. 167: 1173-1181. (Pubitemid 41416267)
28. Jozsi, M., T. Manuelian, S. Heinen, M. Oppermann, and P. F. Zipfel. 2004. Attachment of the soluble complement regulator factor H to cell and tissue surfaces: relevance for pathology. Histol. Histopathol. 19: 251-258. (Pubitemid 38120210)
29. Okemefuna, A. I., H. E. Gilbert, K. M. Griggs, R. J. Ormsby, D. L. Gordon, and S. J. Perkins. 2008. The regulatory SCR-1/5 and cell surface-binding SCR-16/20 fragments of factor H reveal partially folded-back solution structures and different self-associative properties. J. Mol. Biol. 375: 80-101.
30. Herbert, A. P., D. Uhrin, M. Lyon, M. K. Pangburn, and P. N. Barlow. 2006. Disease-associated sequence variations congregate in a polyanion recognition patch on human factor H revealed in three-dimensional structure. J. Biol. Chem. 281: 16512-16520.